CNSP CNS Pharmaceuticals
- 0.1735
- -0.0015-0.86%
CNS Pharmaceuticals News
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
CNS Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
CNS Pharmaceuticals | 8-K/A: Current report (Amendment)
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K/A: Current report (Amendment)
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | S-1: General form for registration of securities under the Securities Act of 1933
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: CNS Pharmaceuticals Reports First Quarter 2024 Financial Results Enrollment completed in potentially pivotal GBM study evaluating Berubicin; Topline data expected in first half of 2025
CNS Pharmaceuticals | S-3: Registration statement for specified transactions by certain issuers
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: Current report
CNS Pharmaceuticals | 8-K: Current report
Analysis
Price Target
No Data
